New Delhi, March 25 -- Wipro GE Healthcare, the 35-year-old joint venture between GE HealthCare and Wipro Enterprises, has started rolling out its $1 billion investment plan to expand manufacturing in India and boost exports, confident that it can dodge the impact of reciprocal tariffs that the US may impose on India's medtech industry.

The company expects to make about 70% of its products for the Indian market locally by 2030, a top executive said, compared with 40-45% currently.

"Our anticipation is that by the end of this period, we will reach somewhere in the vicinity of 70% locally procured, locally manufactured products to meet the Indian market requirement," Chaitanya Sarawate, managing director of Wipro GE Healthcare, told Mint ...